CAS 443913-73-3 appears in our catalog under these names: Vandetanib, Vandetanib, >95% (HPLC), Vandetanib (ZD6474), Vandetanib - Bio-X â„¢, Vandetanib, >98.0%(HPLC)(T). Offered by: Chemat Brand, TRC, GLPBio, Biosynth, TCI. Available pack sizes: on request, 100mg, 10mg, 5mg, 25mg, 10mM (in 1ml dmso), 0,5g, 0,25g.
Vandetanib is a quinazoline that is 7-[(1-methylpiperidin-4-yl)methoxy]quinazoline bearing additional methoxy and 4-bromo-2-fluorophenylamino substituents at positions 6 and 4 respectively. Used for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease. It has a role as an antineoplastic agent and a tyrosine kinase inhibitor. It is a member of piperidines, a secondary amine, an aromatic ether, an organobromine compound, an organofluorine compound and a member of quinazolines.
Source: ChEBI
| Molecular formula | C22H24BrFN4O2 |
|---|---|
| Molecular weight | 475.4 g/mol |
| IUPAC name | N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine |
| InChIKey | UHTHHESEBZOYNR-UHFFFAOYSA-N |
| SMILES | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Computed by PubChem (NCBI)